Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
0.00%
OPERATING MARGIN AVG 15Y
0.00%
OPERATING MARGIN AVG 20Y
0.00%
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 388 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Bone Biologics Corporation
Market Cap
$878396.00
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$885939.00
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$888387.00
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-24.80%
Market Cap
$787624.00
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-935.37%
5Y Avg
-623.58%
Market Cap
$1.02M
Operating Margin
-312016.95%
TTM Avg
-156008.48%
3Y Avg
-78004.24%
5Y Avg
-62403.39%
Market Cap
$707297.00
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.11M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.36M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bone Biologics Corporation (BBLG) | $878396.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| GlucoTrack, Inc. (GCTK)vs › | $885939.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| Decoy Therapeutics Inc. (DCOY)vs › | $888387.00 | 0.00% | 0.00% | 0.00% | -24.80% |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $787624.00 | 0.00% | 0.00% | -935.37% | -623.58% |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.02M | -312016.95% | -156008.48% | -78004.24% | -62403.39% |
| CDT Equity Inc. (CDT)vs › | $707297.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| Clearmind Medicine Inc. (CMND)vs › | $1.11M | 0.00% | 0.00% | 0.00% | 0.00% |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.36M | 0.00% | 0.00% | 0.00% | 0.00% |
| Genprex, Inc. (GNPX)vs › | $1.37M | 0.00% | 0.00% | 0.00% | 0.00% |
| PMGC Holdings Inc. (ELAB)vs › | $1.49M | -1250.11% | -662.88% | -389.78% | -16081.34% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-07-31 | 0.00% |
| 2014-04-30 | 0.00% |
| 2014-01-31 | 0.00% |
| 2013-10-31 | 0.00% |
| 2013-07-31 | 0.00% |
| 2013-04-30 | 0.00% |
| 2013-01-31 | 0.00% |
| 2009-10-31 | 0.00% |
| 2009-01-31 | 0.00% |
| 2008-01-31 | 0.00% |
